Molina Healthcare shares are trading lower on Friday, April 24, 2026, giving back part of the sharp move that followed the company’s first-quarter results and earnings call. The pullback looks tied to positioning and a read-through that, despite a better-than-feared quarter, the company is sticking with a cautious full-year stance and highlighting continued enrollment pressure in Medicaid.

In Q1 2026, Molina reported adjusted EPS of $2.35 on roughly $10.8 billion of total revenue (about $10.2 billion of premium revenue). Management reaffirmed 2026 guidance at approximately $42 billion of premium revenue and at least $5.00 in adjusted EPS, emphasizing prudence early in the year and noting it plans to revisit guidance after Q2 results. (tradingview.com)

A central overhang is the company’s updated expectation for same-store Medicaid membership to decline about 6% in 2026, versus prior guidance of about a 2% decline, with an expected year-end membership level of roughly 4.5 million. While Molina indicated the revenue impact is expected to be offset by Marketplace dynamics, the higher attrition assumption increases uncertainty around mix, margins, and the durability of the earnings ramp later in the year. (marketbeat.com)

Investors will be watching whether medical cost trends remain controlled as 2026 progresses and whether states provide off-cycle or retro rate updates that could support results. Attention is also shifting to the company’s planned Investor Day on May 8, 2026, and to any Q2-driven refresh of full-year guidance that could validate (or challenge) the current earnings floor. (marketbeat.com)